TY  - JOUR
AU  - Otero, Remedios
AU  - Solier-Lopez, Aurora
AU  - Sanchez-Lopez, Veronica
AU  - Oto, Julia
AU  - Arellano, Elena
AU  - Marín, Samira
AU  - Jara-Palomares, Luis
AU  - Elias, Teresa
AU  - Asencio, Maria Isabel
AU  - Blasco-Esquivias, Isabel
AU  - Rodriguez-de-la-Borbolla, Maria
AU  - Sanchez-Diaz, Jose Maria
AU  - Real-Dominguez, Macarena
AU  - Garcia-Cabrera, Emilio
AU  - Rodriguez-Martorell, Francisco Javier
AU  - Medina, Pilar
PY  - 2022
DO  - 10.3390/cancers14112771
SN  - 2072-6694
UR  - http://hdl.handle.net/10668/20900
T2  - Cancers
AB  - The most appropriate duration of anticoagulant treatment for cancer-associated venous thromboembolism (CAT) remains unclear. We have conducted a prospective multicenter study in CAT patients with more than 6 months of anticoagulant treatment to...
LA  - en
PB  - MDPI AG
KW  - biomarkers
KW  - cancer
KW  - cancer-associated thrombosis
KW  - recurrence
KW  - venous thromboembolism
KW  - Humans
KW  - fibrin fragment D
KW  - C-Reactive Protein
KW  - Venous Thromboembolism
KW  - Factor VIII
KW  - Thrombin
KW  - Thromboplastin
TI  - Biomarkers of Venous Thromboembolism Recurrence after Discontinuation of Low Molecular Weight Heparin Treatment for Cancer-Associated Thrombosis (HISPALIS-Study).
TY  - research article
VL  - 14
ER  -